Financhill
Back

Denali Therapeutics Stock Price Chart

  • The current trend is moderately bullish and DNLI is experiencing slight selling pressure.

Denali Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 28.93 Sell
20-day SMA: 29.18 Sell
50-day SMA: 25.93 Buy
200-day SMA: 21.16 Buy
8-day EMA: 28.94 Sell
20-day EMA: 28.55 Buy
50-day EMA: 26.55 Buy
200-day EMA: 23.03 Buy

Denali Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 54.3 Buy
Chaikin Money Flow: -56409 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.21 - 30.49) Buy
Bollinger Bands (100): (20.39 - 26.93) Buy

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Denali Therapeutics Stock

Is Denali Therapeutics Stock a Buy?

DNLI Technical Analysis vs Fundamental Analysis

Sell
39
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics a Buy or a Sell?

Denali Therapeutics Stock Info

Market Cap:
4.1B
Price in USD:
28.63
Share Volume:
360.53K

Denali Therapeutics 52-Week Range

52-Week High:
32.13
52-Week Low:
14.56
Sell
39
Denali Therapeutics (DNLI) is a Sell

Denali Therapeutics Share Price Forecast

Is Denali Therapeutics Stock a Buy?

  • Denali Therapeutics share price is 28.63 while DNLI 8-day exponential moving average is 28.94, which is a Sell signal.
  • The stock price of DNLI is 28.63 while Denali Therapeutics 20-day EMA is 28.55, which makes it a Buy.
  • Denali Therapeutics 50-day exponential moving average is 26.55 while DNLI share price is 28.63, making it a Buy technically.
  • DNLI stock price is 28.63 and Denali Therapeutics 200-day simple moving average is 23.03, creating a Buy signal.

Fundamental Analysis of Denali Therapeutics

Is Denali Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.

Technical Analysis of Denali Therapeutics

Should I short Denali Therapeutics stock?

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.